Nursing and Health Professions
Patient
100%
Remission
50%
Acute Lymphoblastic Leukemia
37%
Melphalan
37%
Transplantation
25%
Drug Megadose
25%
Methotrexate
25%
Vincristine
25%
Maintenance Therapy
25%
Prednisone
25%
Mercaptopurine
25%
Autograft
25%
Relapse
25%
Diseases
12%
Standard
12%
Mortality
12%
Analysis
12%
Survival
12%
Autotransplantation
12%
Medicine and Dentistry
Spontaneous Remission
50%
Acute Lymphoblastic Leukemia
37%
Melphalan
37%
Transplantation
25%
Vincristine
25%
Drug Megadose
25%
Autograft
25%
Cumulative Incidence
25%
Methotrexate
25%
Prednisone
25%
Maintenance Therapy
25%
Mercaptopurine
25%
Maintenance Chemotherapy
25%
Adult
25%
Relapse
25%
Diseases
12%
Leukemia
12%
Karyotype
12%
Autotransplantation
12%
Age
12%
Mortality
12%
Analysis
12%
Survival
12%
INIS
patients
50%
maintenance
50%
leukemia
50%
risks
37%
probability
37%
therapy
25%
transplants
25%
doses
25%
chemotherapy
25%
prednisone
25%
methotrexate
25%
mercaptopurine
25%
data
12%
adults
12%
diseases
12%
mortality
12%
karyotype
12%
Pharmacology, Toxicology and Pharmaceutical Science
Remission
50%
Acute Lymphoblastic Leukemia
37%
Melphalan
37%
Methotrexate
25%
Prednisone
25%
Mercaptopurine
25%
Vincristine
25%
Relapse
25%
Diseases
12%
Mortality
12%
Survival
12%
Immunology and Microbiology
Transplantation
25%
Drug Megadose
25%
Autograft
25%
Prednisone
25%
Methotrexate
25%
Incidence
25%
Autotransplantation
12%
Karyotype
12%
Mortality
12%
Age
12%
Survival
12%